# cisatracurium besylate

NDC: 0781-3152
Generic name: cisatracurium besylate
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20120716

FDA application: ANDA200159

## Active ingredients

- CISATRACURIUM BESYLATE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0781-3152"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0781-3152
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2ee0358e-2cce-40d3-9fcf-1b9088815c98